Managing Partner
Mark Rangell’s career spans over 30 years of executive leadership in the healthcare and information technology industries, with primary experience in strategy, marketing, business development and product management across all phases of business maturity from startup operations through established business units.
Prior to Execullence, Mark co-founded and served as President of Applied Pathways, a healthcare software company serving the provider and payer communities. In his prior healthcare strategy firm, Mark served as interim COO for a leading home healthcare solutions provider and a venture-backed medical diagnostics company. He also co-founded and served as EVP of Quovadx, provider of software and services for enterprise application integration, claims and quality management to worldwide customers across the healthcare continuum, and has held senior positions in marketing and product management with Thomson Healthcare, Novartis and IBM.
Mark received his BS degree from NYU and his MS degree from the MIT Sloan School of Management.
Bob Merold, Managing Director
Bob Merold’s career spans over 30 years in health care informatics leadership, ranging from Fortune 500 companies Procter & Gamble, Bristol-Myers Squibb and IMS Health to venture-backed startups. He has deep expertise in general management, product management, marketing and new business development.
After a decade in executive positions at P&G and BMS, Bob spent the next decade as Global SVP of Product for IMS Health, where he developed and led their flagship Xponent prescription data product along with overseeing global strategy for their CRM business. He then shifted to the startup world, running both a genomic startup, followed by one of the first commercial efforts in healthcare NLP data mining space.
For most of the past 15 years, he has been a retained consultant to healthcare VC and PE firms, helping them and their portfolio companies identify and execute new business opportunities, and serving on three corporate Boards. Recently, he concluded a two year assignment as Chief of Strategic Initiatives for ASCO’s big data rapid learning system, CancerLinQ, which he helped lead to a successful external strategic partnership.
Bob received his BA from the University of Pennsylvania.
Dale Schuster, Managing Director
Dale Schuster’s career spans over 35 years of executive leadership in the software, information technology, energy, and medical device industries. He is primarily focused on global business development, business and project turnarounds, product development, marketing and general management.
Prior to joining Execullence, Dale served as President of SteriTec Products, Inc., a global medical device company focused on the design and development of monitoring products for the medical and canning industries. While at SteriTec, Dale oversaw an extended period of significant global growth, resulting in the successful sale of the business to Getinge Group, a global product and systems provider to the healthcare and life sciences market. Since 2012, Dale continued his multi-year track record of leadership, growth and profitability within the Surgical Workflow